NextCell Pharma AB (FRA:65G)

NextCell Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is September - August.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Cash & Equivalents	38.72	46.79	50.03	97.12	139.17
Cash & Short-Term Investments	38.72	46.79	50.03	97.12	139.17
Cash Growth	-17.24%	-6.47%	-48.49%	-30.22%	533.78%
Accounts Receivable	3	1.67	2.35	1.78	1.39
Other Receivables	1.98	1.45	1.24	0.93	0.31
Receivables	4.98	3.12	3.58	2.71	1.7
Inventory	0.55	0.55	0.79	0.77	-
Prepaid Expenses	10.15	10.17	12.87	6.16	5.61
Other Current Assets	-	0.05	0	-	-
Total Current Assets	54.4	60.67	67.27	106.75	146.48
Property, Plant & Equipment	14.33	12.66	13.55	9.9	2.9
Long-Term Investments	6.87	6.92	6.87	6.87	5.11
Other Long-Term Assets	1.14	1.03	1.13	1.13	1.13
Total Assets	76.73	81.29	88.83	124.66	155.63
Accounts Payable	2.69	6.16	0.89	1.92	1.28
Accrued Expenses	2.25	2.49	7.65	4.16	0.59
Current Unearned Revenue	-	0.25	0.2	-	-
Other Current Liabilities	0.49	0.98	1.35	0.85	2.08
Total Current Liabilities	5.43	9.87	10.08	6.93	3.96
Long-Term Unearned Revenue	4.92	3.82	3.02	2.18	1.58
Other Long-Term Liabilities	-0	-0	-0	-	-
Total Liabilities	10.34	13.69	13.1	9.12	5.53
Common Stock	22.84	14.98	7.05	7.05	7.05
Additional Paid-In Capital	248.41	222.33	196.43	196.43	196.43
Retained Earnings	-204.85	-169.71	-127.75	-87.94	-53.38
Shareholders' Equity	66.39	67.6	75.73	115.54	150.09
Total Liabilities & Equity	76.73	81.29	88.83	124.66	155.63
Net Cash (Debt)	38.72	46.79	50.03	97.12	139.17
Net Cash Growth	-17.24%	-6.47%	-48.49%	-30.22%	533.78%
Net Cash Per Share	0.51	1.15	1.46	2.82	4.58
Filing Date Shares Outstanding	111.39	73.09	34.38	34.38	34.38
Total Common Shares Outstanding	111.39	73.09	34.38	34.38	34.38
Working Capital	48.97	50.8	57.19	99.82	142.52
Book Value Per Share	0.60	0.92	2.20	3.36	4.37
Tangible Book Value	66.39	67.6	75.73	115.54	150.09
Tangible Book Value Per Share	0.60	0.92	2.20	3.36	4.37
Machinery	-	16.04	5.22	5.15	5.25
Construction In Progress	-	-	11.59	7.56	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.